Determination of lapatinib concentrations in the plasma and tumor tissues of tumor-bearing mice by LC-MS / MS

wang zhengrong,wan xu,pang xiaoying,zheng xiaoyao,zhang qizhi

DOI: https://doi.org/10.19577/j.cnki.issn10074406.2015.03.003

2015-01-01

Abstract:AIM To develop an LC-MS /MS method for determination of lapatinib concentrations in the plasma and tumor tissues of tumor-bearing mice. METHODS The analytes and the internal standard( IS,gefitinib) were extracted from 100 μL aliquots of plasma and tumor homogenate by methanol precipitation. Chromatographic separation was achieved on an Agilent Eclipse XDB C18column( 150 mm × 2. 1 mm,5 μm) in a run time of 3 min with the mobile phase consisted of methanol and water( containing 2 nmol·L-1ammonium acetate and 0.1% formic acid) at the ratio of( 90∶ 10),which was pumped at a flow rate of 0. 4 m L·min-1. The column temperature was set for 40℃ and the injection volume was 20 μL. Detection of analytes and IS was done by tandem mass spectrometry,operated in positive ion and multiple reaction monitoring( MRM) mode. RESULTS The liner range of lapatinib in mice plasma and tumor tissues was 25-25 000 μg·L-1and 1-2 000 μg·L-1,respectively. The intra-batch RSD was less than 1. 4% and 8. 3% respectively,and the inter-batch RSD was less than 3. 7%and 7. 8% respectively. The extraction recoveries were 99. 4%-102. 3% and 87. 7%-94. 1%,respectively. The matrix effects were all within 85%-115%. CONCLUSION The method is sensitive,accurate and fast,and suitable for the determination of lapatinib concentrations in tumor tissues after oral administration.